- Home
- AQST vs SOR Comparison
AQST vs SOR Comparison
Compare AQST & SOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AQST
- SOR
- Stock Information
- Founded
- AQST 2004
- SOR 1968
- Country
- AQST United States
- SOR United States
- Employees
- AQST N/A
- SOR N/A
- Industry
- AQST Biotechnology: Pharmaceutical Preparations
- SOR Investment Managers
- Sector
- AQST Health Care
- SOR Finance
- Exchange
- AQST Nasdaq
- SOR Nasdaq
- Market Cap
- AQST 390.4M
- SOR 358.4M
- IPO Year
- AQST 2018
- SOR N/A
- Fundamental
- Price
- AQST $3.96
- SOR $43.99
- Analyst Decision
- AQST Strong Buy
- SOR
- Analyst Count
- AQST 7
- SOR 0
- Target Price
- AQST $11.29
- SOR N/A
- AVG Volume (30 Days)
- AQST 1.1M
- SOR 16.2K
- Earning Date
- AQST 08-11-2025
- SOR 01-01-0001
- Dividend Yield
- AQST N/A
- SOR 7.24%
- EPS Growth
- AQST N/A
- SOR N/A
- EPS
- AQST N/A
- SOR 6.50
- Revenue
- AQST $54,228,000.00
- SOR N/A
- Revenue This Year
- AQST N/A
- SOR N/A
- Revenue Next Year
- AQST $51.62
- SOR N/A
- P/E Ratio
- AQST N/A
- SOR $6.41
- Revenue Growth
- AQST 5.29
- SOR N/A
- 52 Week Low
- AQST $2.12
- SOR $36.41
- 52 Week High
- AQST $5.80
- SOR $42.75
- Technical
- Relative Strength Index (RSI)
- AQST 50.64
- SOR 59.71
- Support Level
- AQST $3.73
- SOR $43.16
- Resistance Level
- AQST $4.10
- SOR $44.58
- Average True Range (ATR)
- AQST 0.22
- SOR 0.98
- MACD
- AQST -0.07
- SOR -0.04
- Stochastic Oscillator
- AQST 17.42
- SOR 69.07
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.
About SOR Source Capital Inc.
Source Capital Inc is a diversified, closed-end management investment company. The investment objective of the company is to seek maximum total return for Common shareholders from both capital appreciation and investment income to the extent consistent with the protection of invested capital.